Philipp Jungebluth
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Philipp Jungebluth has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Beatriz Pelaz
Universidade de Santiago de Compostela
1 shared publication - Cornelia Brendel
Department of Hematology, Oncology and Immunology, Philipps University Marburg, University Hospital Giessen and Marburg, Marburg, Germany
1 shared publication Helmut Ostertag
General Thoracic Surgical Experimental Laboratory, Universitat de Barcelona, Fundació Clínic, and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBABS), Barcelona, Spain
1 shared publication- Holger Hackstein
Department of Transfusion Medicine and Hemostaseology, University Hospital Erlangen, Erlangen, Germany, fau.eu
1 shared publication - Jonas Hühn
Department of Physics, Philipps-University of Marburg, Marburg, Germany
1 shared publication - Karsten Kantner
Philipps University of Marburg, Renthof 7, 35032, Marburg, Germany
1 shared publication
Latest Publications
- Open Access
- 29 March 2017
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 15 (1) , 1-11
Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
Mesenchymal stromal cells (MSCs) have an inherent migratory capacity towards tumor tissue in vivo. With the future objective to quantify the tumor homing efficacy of MSCs, as first step in this direction we investigated the use of inorganic nanoparticles (NPs), in particular ca. 4 nm-sized Au NPs, for MSC labeling. Time dependent uptake efficiencies of NPs at different exposure concentrations and times were determined via inductively coupled plasma mass spectrometry (ICP-MS). The labeling efficiency of the MSCs was determined in terms of the amount of exocytosed NPs versus the amount of initially endocytosed NPs, demonstrating that at high concentrations the internalized Au NPs were exocytosed over time, leading to continuous exhaustion. While exposure to NPs did not significantly impair cell viability or expression of surface markers, even at high dose levels, MSCs were significantly affected in their proliferation and migration potential. These results demonstrate that proliferation or migration assays are more suitable to evaluate whether labeling of MSCs with certain amounts of NPs exerts distress on cells. However, despite optimized conditions the labeling efficiency varied considerably in MSC lots from different donors, indicating cell specific loading capacities for NPs. Finally, we determined the detection limits of Au NP-labeled MSCs within murine tissue employing ICP-MS and demonstrate the distribution and homing of NP labeled MSCs in vivo. Although large amounts of NPs improve contrast for imaging, duration and extend of labeling needs to be adjusted carefully to avoid functional deficits in MSCs. We established an optimized labeling strategy for human MSCs with Au NPs that preserves their migratory capacity in vivo.
- 29 March 2017
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 15 (1) , 1-11
Open AccessOptimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
Mesenchymal stromal cells (MSCs) have an inherent migratory capacity towards tumor tissue in vivo. With the future objective to quantify the tumor homing efficacy of MSCs, as first step in this direction we investigated the use of inorganic nanoparticles (NPs), in particular ca. 4 nm-sized Au NPs, for MSC labeling. Time dependent uptake efficiencies of NPs at different exposure concentrations and times were determined via inductively coupled plasma mass spectrometry (ICP-MS). The labeling efficiency of the MSCs was determined in terms of the amount of exocytosed NPs versus the amount of initially endocytosed NPs, demonstrating that at high concentrations the internalized Au NPs were exocytosed over time, leading to continuous exhaustion. While exposure to NPs did not significantly impair cell viability or expression of surface markers, even at high dose levels, MSCs were significantly affected in their proliferation and migration potential. These results demonstrate that proliferation or migration assays are more suitable to evaluate whether labeling of MSCs with certain amounts of NPs exerts distress on cells. However, despite optimized conditions the labeling efficiency varied considerably in MSC lots from different donors, indicating cell specific loading capacities for NPs. Finally, we determined the detection limits of Au NP-labeled MSCs within murine tissue employing ICP-MS and demonstrate the distribution and homing of NP labeled MSCs in vivo. Although large amounts of NPs improve contrast for imaging, duration and extend of labeling needs to be adjusted carefully to avoid functional deficits in MSCs. We established an optimized labeling strategy for human MSCs with Au NPs that preserves their migratory capacity in vivo.
- 1 June 2008
- Published by Elsevier in Journal of Surgical Research
- Vol. 147 (1) , 75-78
An Experimental Animal Model of Postobstructive Pulmonary Hypertension
- 1 June 2008
- Published by Elsevier in Journal of Surgical Research
- Vol. 147 (1) , 75-78
An Experimental Animal Model of Postobstructive Pulmonary Hypertension